telmisartan has been researched along with Bilirubinemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Igarashi, T; Kato, Y; Nishino, A; Sugiyama, Y | 1 |
1 other study(ies) available for telmisartan and Bilirubinemia
Article | Year |
---|---|
Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anion Transport Proteins; Benzimidazoles; Benzoates; Biliary Tract; Carbon Radioisotopes; Carrier Proteins; Glucuronides; Hyperbilirubinemia; Injections, Intravenous; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Telmisartan | 2000 |